Abstract
Abstract
The objective of these experiments was to assess the possibility that the increase in tail skin temperature (TSK) accompanying administration of the β-adrenergic agonist isoproterenol (ISO) was mediated by angiotensin II (Angll) as a result of stimulation of renin release by ISO. Although Angll is known to be a potent vasoconstrictor in mammals, acute administration of this peptide to rats induces a vasodilation of blood vessels in the tail and an increase in TSK. The objective was approached in several ways: (i) use of the nonpeptide Angll receptor antagonist losartan potassium (DuP 753); (ii) use of the peptide Angll receptor antagonist saralasin; (iii) use of the Angl-converting enzyme inhibitor captopril, and (iv) chronic administration of Angll. The rationale for these experiments was that blockade of Angll receptors (Experiments 1 and 2), inhibition of the enzyme that converts Angl to Angll (Experiment 3), or down-regulation of the Angll receptors (Experiment 4) would be expected to prevent any contribution to the ISO-induced increase in TSK by Angll. The results of these experiments are consistent in revealing that the response of TSK to ISO administration is due in part (approximately 55%) to a direct effect of ISO and in part (approximately 45%) to an indirect effect resulting from the ISO-stimulated release of renin from the kidneys and the formation of Angll in the blood.
Get full access to this article
View all access options for this article.
